SCHEMBL8548877

SCHEMBL8548877

O=C(NC(=O)[C@@H]1CCCN1CC(=O)c1ccccc1OC(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.43
SLC6A3 Q01959 1/20 0.43
KMT2A Q03164 2/20 0.42
GAA P10253 1/20 0.42
ALDH1A1 P00352 3/20 0.41
MAPT P10636 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
STAT3 P40763 1/20 0.41
CTSK P43235 9/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
POLB P06746 1/20 0.38
CHRNB2 P17787 1/20 0.38
CHRNA5 P30532 1/20 0.38
CHRNA7 P36544 1/20 0.38
CHRNA4 P43681 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8548878 1.00 NPSR1 (0.43) NPSR1SLC6A3KMT2AGAAALDH1A1
SCHEMBL8548300 0.89 NPC1 (0.48) NPSR1KMT2AALDH1A1MAPTCTSK
SCHEMBL8548308 0.89 NPC1 (0.48) NPSR1KMT2AALDH1A1MAPTCTSK
SCHEMBL8548109 0.88 NPSR1 (0.43) NPSR1KMT2AGAAALDH1A1CTSK
SCHEMBL8548100 0.88 NPSR1 (0.43) NPSR1KMT2AGAAALDH1A1CTSK
SCHEMBL8548880 0.86 ALDH1A1 (0.54) NPSR1KMT2AALDH1A1CYP2C9CYP2C19
SCHEMBL8548486 0.84 CTSK (0.46) NPSR1KMT2AALDH1A1MAPTCTSK
SCHEMBL8548482 0.84 CTSK (0.46) NPSR1KMT2AALDH1A1MAPTCTSK
SCHEMBL8543316 0.83 CTSK (0.53) NPSR1KMT2AGAAALDH1A1MAPT
SCHEMBL8543314 0.83 CTSK (0.53) NPSR1KMT2AGAAALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0564924-B1 2-Oxoethyl derivatives as immunosuppressants BAYER AG (US) 1998-09-09 EP claimed
EP-0564924-A2 2-Oxoethyl derivatives as immunosuppressants Bayer Corporation (US) 1993-10-13 EP claimed
EP-0564924-B1 2-Oxoethyl derivatives as immunosuppressants BAYER AG (US) 1998-09-09 EP disclosed
US-5686424-A FOR TREATING INFLAMMATION MILES INC. (US) 1997-11-11 US disclosed
EP-0564924-A2 2-Oxoethyl derivatives as immunosuppressants Bayer Corporation (US) 1993-10-13 EP disclosed